Evidence map›Paper›PMID 41486328›Full record

ArticleJapanese journal of radiology2026

Liping Yang, Tianyu She, Zhiyun Jiang, Shichuan Xu, Yuan Wang, Shijia Liu, Kezheng Wang, Ping Li, Xiaoyi Duan

Abstract read
PubMed Publisher
In one paragraph

Article in Japanese journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Liping Yang *Department of PET-CT, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Tianyu She *Department of Ultrasound, Xi'an Electric Power Central Hospital, Xi'an, China.
Zhiyun JiangDepartment of PET-CT, Harbin Medical University Cancer Hospital, Harbin, China.
Shichuan XuDepartment of Equipment, The Second Hospital of Harbin, Harbin, China.
Yuan WangDepartment of Ultrasound, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Shijia LiuDepartment of PET-CT, Harbin Medical University Cancer Hospital, Harbin, China.
Kezheng WangDepartment of PET-CT, Harbin Medical University Cancer Hospital, Harbin, China.
Ping LiDepartment of PET-CT, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. lipinghmu@163.com.
Xiaoyi DuanDepartment of PET-CT, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. duanxy@mail.xjtu.edu.cn.

Funding

Haiyan Fund of Harbin Medical University Cancer Hospital JJMS-2023-05
6 · The paper itself

Abstract

purposeThis study evaluates the prognostic value of baseline

resultsBoth wbPSMA-TV (r = 0.70) and wbTL-PSMA (r = 0.67) correlated with baseline PSA. Multivariable analysis identified bone metastasis count (adjusted OR [aOR] 0.19, 95% CI 0.11-0.35; P < 0.001) and wbPSMA-TV (aOR = 0.77, 95% CI 0.65-0.91; P < 0.001) as independent predictors of early PSA response. Baseline wbTL-PSMA ≥ 231.4 SUV cm

conclusionBaseline

Indexed as

Androgen Receptor AntagonistsNiacinamideOligopeptidesPositron Emission Tomography Computed TomographyProstatic Neoplasms, Castration-ResistantAgedAged, 80 and overFluorine RadioisotopesHumansMaleMiddle AgedPrognosisProstate-Specific AntigenRadiopharmaceuticalsRetrospective StudiesTumor BurdenAndrogen Receptor AntagonistsFluorine RadioisotopesNiacinamideOligopeptidesProstate-Specific AntigenPSMA-1007Radiopharmaceuticals18F-PSMA-1007 PET/CTMetastatic castration-resistant prostate cancerOverall survivalRisk factor modelTotal tumor volume

Identifiers

PMID41486328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.